For cardiovascular and respiratory use this is Red in the Black Country IMOG formulary, i.e. for hospital prescribing only.

Suitable for self-care/purchase, if appropriate.

Prescribe Beconase and Nasobec by brand. Check individual products for formulary status.

Diprosone is AR in the Black Country IMOG formulary, i.e. it may be prescribed in primary care after a specialist recommendation.

Tabets for Gastroenterology use only. The tablets and enemas are AR in the Black Country formulary, i.e. for prescribing in primary care after specialist recommendation. The orodispersible tablets (Jorveza) are Red in the Black Country formulary, i.e. for hosital prescribing only.

For respiratory uses check individual formulations to check formulary status and prescribe by brand.

Targeted release budesonide (Kinpeygo) is indicated for the treatment of primary immunoglobulin A (IgA) nephropathy in line with NICE TA 937 is funded by ICB. Blueteq form must be completed for Black Country ICB.

Check individual products for formulary status.

The Flixonase nasal drops and Flixotide nebuliser liquid are AI in the Black Country IMOC formulary, i.e. can be prescribed in primary care after specialist initiation

The inhalers are Black, i.e. non-formulary, in the Black Country IMOC formulary but the nebuliser liquid is Green.

The Black Country IMOC formulary status of triamcinolone products is dependent on the indication: For endocrine indications the status is Black for musculoskeletal and neurology indications products will be in the formulary.